Contents

• Introduction
• Literature Review
• Stem Cells to produce Insulin for treating Diabetes
• References

Description

Diabetes is one of the diseases, which is affecting more and more people across the world. More than 300 million people across the globe are affected by it and costs around 12% of the total health cost of the world (Allahverdi et al., 2015, p.231). In Type 1 diabetes the person’s immunologically-mediated devastation of insulin producing cells in the pancreatic islet occurs and to control it several daily injections are essential for survival (Paek et al., 2014, p.235). The diabetic patients require effective and intensive disease management as it can lead to wide range of complication if there is inaccuracy in insulin dosing (Okere et al., 2016, p.1). Diabetes of type 1 is commonly treated using daily insulin injections along with blood glucose monitoring regularly (Mojibian et al., 2016, p.87). Since the administration of exogenous does not mimic the physiological activity of the islet, diabetes continues to progress with development of other serious health conditions such as vascular disease, kidney failure and retinopathy (Okere et al., 2016, p.1). One of the new promising treatment for the diabetic patients is using stem cells that produce β-cells. The use of stem cells to restore insulin production is gaining importance as an ideal treatment, which can overcome the therapeutic barriers (Mojibian et al., 2016, p.87). The stem cells have shown the potential to renew cells on its own and differentiate into one or few specific cell lineages of the tissue in which they are found and repair the organ of origin and also maintain it allowing the patient to overcome the effects of diabetes (Allahverdi et al., 2015, p.233). This essay discusses the effectiveness of use of stem cells in producing insulin for treating diabetes.